Key Takeaways
- C3.ai and UiPath represent two distinct approaches to enterprise AI: C3.ai sells ready‑to‑use AI applications for sectors such as defense, manufacturing, and oil & gas, while UiPath offers an end‑to‑end robotic process automation (RPA) platform augmented with AI agents to orchestrate complex workflows.
- Financial performance diverges sharply: UiPath posted FY‑2026 revenue of $1.6 billion (13% YoY growth) and net income of $282.3 million (net margin 17.5%), whereas C3.ai’s FY‑2026 revenue fell to $250.3 million (‑35.7% YoY) with a net loss of $470.4 million (net margin ‑187.9%).
- Liquidity metrics favor C3.ai (current ratio 6.6×, zero debt‑to‑equity) but its free cash flow is negative (‑$190.7 million); UiPath shows a healthier cash generation profile (free cash flow $352.2 million) despite a lower current ratio (2.5×).
- Both companies face customer‑concentration risk, but UiPath also contends with reliance on third‑party cloud providers and integration challenges from rapid growth and acquisitions; C3.ai’s risks center on its transition to a consumption‑based pricing model and regulatory headwinds such as the EU AI Act.
- Valuation analysis suggests UiPath is the more attractively priced stock, trading at a lower sales multiple, while C3.ai lacks a forward P/E due to its unprofitability and near‑term earnings outlook.
- The author’s recommendation for 2026 favors UiPath, citing its accelerating sales growth, improving profitability, and stronger financial health, whereas C3.ai’s rebound remains uncertain after leadership turbulence and continued sales declines.
Introduction: Competing Visions of Enterprise AI
As the race for enterprise AI automation intensifies, investors are weighing different paths to potential profit. Is the pure‑play approach of C3.ai (NYSE:AI) or the orchestration power of UiPath (NYSE:PATH) the better buy? The article frames the dilemma by noting that “both companies represent different segments of the modern intelligence revolution” and that they “compete for corporate budgets as businesses modernize their workflows, making a direct comparison essential for investors.” This sets the stage for a side‑by‑side look at product focus, financials, risks, and valuation.
The Case for C3.ai: Ready‑to‑Use AI for Heavy Industries
C3.ai provides ready‑to‑use artificial intelligence applications for government and industrial sectors, targeting defense, manufacturing, and oil and gas. The firm historically relied on high‑value partners such as Baker Hughes but is shifting to a consumption‑based pricing model to lure smaller customers. Financially, the picture is bleak: “In its 2026 fiscal year (FY) ended April 30, revenue reached $250.3 million, which represented a decrease of 35.7% compared to the prior year.” The company reported a net loss of $470.4 million, yielding a net margin of negative 187.9%—meaning it lost nearly two dollars for every dollar of revenue. Despite the losses, liquidity appears strong: the current ratio stands at 6.6×, debt‑to‑equity is zero, though free cash flow was a loss of $190.7 million.
The Case for UiPath: RPA Meets AI Orchestration
UiPath offers an end‑to‑end platform that combines robotic process automation with new AI agents to orchestrate complex business processes. It serves thousands of global customers, including many large enterprises that contribute over $1 million in annual recurring revenue. The financial story contrasts sharply with C3.ai’s: “In FY 2026 ended Jan. 31, revenue reached $1.6 billion, representing growth of 13% over the previous fiscal year. The company achieved net income of $282.3 million, yielding a net margin of 17.5%.” UiPath’s balance sheet shows a current ratio of 2.5×, zero debt‑to‑equity, and free cash flow of $352.2 million. The article notes that stock‑based compensation (SBC) accounted for 78.3% of operating cash flow, inflating reported cash generation because SBC is a non‑cash expense added back in the cash flow statement.
Risk Profile Comparison: Concentration, Regulation, and Integration
Both firms share exposure to customer concentration, but the nuances differ. C3.ai must navigate intense AI competition, evolving global regulations like the EU AI Act that could raise compliance costs, and the ongoing transition to a consumption‑based sales model. UiPath, meanwhile, is vulnerable to service interruptions from third‑party cloud infrastructure providers and faces challenges managing rapid organizational growth, integrating recent acquisitions, and competing against entrenched software giants such as Microsoft. The article emphasizes that “UiPath also contends with customer concentration, as a small percentage of its largest clients accounts for a substantial portion of its total revenue.”
Valuation Comparison: Why UiPath Looks Cheaper
When it comes to valuation, UiPath appears more attractively priced than its peer. It carries a lower multiple on annual sales, whereas C3.ai lacks a forward P/E ratio because it remains unprofitable and is not expected to turn a profit in the near term. The valuation metrics are sourced from Financial Modeling Prep (FMP), with the caveat that they may differ across data providers. This disparity in pricing reinforces the notion that investors are rewarding UiPath’s current profitability and growth trajectory over C3.ai’s speculative turnaround story.
Which Stock Would I Buy in 2026? The Author’s Pick
Although both companies operate in the hot field of artificial intelligence, the author concludes that UiPath is the better investment. The rationale hinges on recent performance: “UiPath’s business is expanding. Its fiscal 2026 sales growth of 13% was solid, and that percentage has accelerated to a 17% year‑over‑year increase to $418 million in its fiscal first quarter ended April 30.” UiPath forecasts fiscal 2027 revenue of about $1.8 billion, up from $1.6 billion the prior year, while C3.ai expects another year of declining sales, with guidance between $210 million and $240 million versus $250.3 million in FY 2026. Financially, UiPath’s strength is evident: “While C3.ai is not a profitable company, UiPath reported fiscal Q1 net income of $22.5 million.” The author also notes that C3.ai’s struggles were exacerbated by the resignation (and later return) of CEO Thomas Siebel, which disrupted sales momentum.
Should You Buy Stock in C3.ai Right Now? A Motley Fool Plug
The piece then shifts to a promotional segment for The Motley Fool’s Stock Advisor service, cautioning readers that C3.ai did not make the firm’s list of “10 best stocks for investors to buy now.” It cites historical examples—Netflix and Nvidia—to illustrate the service’s track record, noting that Stock Advisor’s total average return is 986%, far outpacing the S&P 500’s 214%. The plug encourages readers to subscribe for the latest top‑10 list and join the investing community. While this section is clearly advertorial, it underscores the broader sentiment that C3.ai is presently viewed as a higher‑risk, speculative pick compared to more established winners.
Disclosures and Transparency
The article ends with standard disclosures: Robert Izquierdo holds positions in C3.ai, Microsoft, and UiPath; The Motley Fool holds positions in and recommends Microsoft and UiPath, and also recommends C3.ai. A disclosure policy is referenced, reminding readers of potential conflicts of interest.
Conclusion
In summary, the comparison paints UiPath as the financially healthier, growing, and more attractively valued AI automation play, while C3.ai remains a turnaround candidate weighed down by declining revenue, deep losses, and an uncertain path to profitability. Investors seeking exposure to enterprise AI must weigh UiPath’s steady execution against C3.ai’s potential upside if it successfully executes its consumption‑based model and regains momentum in its core industrial markets.
https://finance.yahoo.com/technology/ai/articles/c3-ai-vs-uipath-artificial-033218830.html